Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Lachmann

Showing results (91-100 of 287) with videos related to

Pageof 29
Sort By:
Molecular Immunology|February 1, 1980
Novel cleavage products of the third component of human complementR A Harrison, P J Lachmann
Clinical and Experimental Immunology|December 1, 1982
In vitro modulation of viral cell surface glycoproteins by anti-viral antibody in the presence of complementN T Gorman, P J Lachmann
Transplantation Reviews|January 1, 1976
Allotypes of complement components in manM J Hobart, P J Lachmann
Clinical and Experimental Immunology|January 1, 1977
A second case of human C3b inhibitor (KAF) deficiencyR A Thompson, P J Lachmann
Lancet (London, England)|March 27, 1976
C1 inhibitor in malignant diseasesP J Lachmann, J Wragge-Morley
Journal of Immunological Methods|August 3, 1987
Activation of the third component of complement (C3) detected by a monoclonal anti-C3'g' neoantigen antibody in a one-step enzyme immunoassayT E Mollnes, P J Lachmann
Scandinavian Journal of Immunology|January 1, 1974
The fractionation of antigen-dependent macrophage migration inhibition and macrophage activation factors from lymph draining a tuberculin reactionD M Lowe, P J Lachmann
Clinical and Experimental Immunology|February 1, 1979
IgG synthesis within the brain in multiple sclerosis and subacute sclerosing panencephalitisP W Ewan, P J Lachmann
Springer Seminars in Immunopathology|January 1, 1984
Initiation of complement activationP J Lachmann, N C Hughes-Jones
Immunology|June 1, 1976
Variable region (Fv) determinants on mouse lymphocytesI McConnell, P J Lachmann, D Givol
Pageof 29

Showing results (91-100 of 287) with videos related to

Sort By:
Pageof 29
Molecular Immunology|February 1, 1980
Novel cleavage products of the third component of human complementR A Harrison, P J Lachmann
Clinical and Experimental Immunology|December 1, 1982
In vitro modulation of viral cell surface glycoproteins by anti-viral antibody in the presence of complementN T Gorman, P J Lachmann
Transplantation Reviews|January 1, 1976
Allotypes of complement components in manM J Hobart, P J Lachmann
Clinical and Experimental Immunology|January 1, 1977
A second case of human C3b inhibitor (KAF) deficiencyR A Thompson, P J Lachmann
Lancet (London, England)|March 27, 1976
C1 inhibitor in malignant diseasesP J Lachmann, J Wragge-Morley
Journal of Immunological Methods|August 3, 1987
Activation of the third component of complement (C3) detected by a monoclonal anti-C3'g' neoantigen antibody in a one-step enzyme immunoassayT E Mollnes, P J Lachmann
Scandinavian Journal of Immunology|January 1, 1974
The fractionation of antigen-dependent macrophage migration inhibition and macrophage activation factors from lymph draining a tuberculin reactionD M Lowe, P J Lachmann
Clinical and Experimental Immunology|February 1, 1979
IgG synthesis within the brain in multiple sclerosis and subacute sclerosing panencephalitisP W Ewan, P J Lachmann
Springer Seminars in Immunopathology|January 1, 1984
Initiation of complement activationP J Lachmann, N C Hughes-Jones
Immunology|June 1, 1976
Variable region (Fv) determinants on mouse lymphocytesI McConnell, P J Lachmann, D Givol
Pageof 29